Redox activation of mitochondrial DAMPs and the metabolic consequences for development of autoimmunity

A Koenig, IA Buskiewicz-Koenig - Antioxidants & Redox Signaling, 2022 - liebertpub.com
Significance: Reactive oxygen species (ROS) are well known to promote innate immune
responses during and in the absence of microbial infections. However, excessive or …

[HTML][HTML] Pediatric antiphospholipid syndrome

JA Madison, Y Zuo, JS Knight - European Journal of Rheumatology, 2020 - ncbi.nlm.nih.gov
Despite its potential to cause significant morbidity in children, pediatric antiphospholipid
syndrome (APS) is an understudied condition. In this review, we will cover what is known …

[HTML][HTML] Antiphospholipid antibodies and lipids in hematological malignancies

SG Barreno-Rocha, S Guzmán-Silahua… - International Journal of …, 2022 - mdpi.com
One of the main groups of lipids is phospholipids, which are mainly involved in forming cell
membranes. Neoplastic processes such as cell replication have increased lipid synthesis …

[HTML][HTML] Advances in the pathophysiology of thrombosis in antiphospholipid syndrome: molecular mechanisms and signaling through lipid rafts

A Capozzi, V Manganelli, G Riitano, D Caissutti… - Journal of Clinical …, 2023 - mdpi.com
The pathological features of antiphospholipid syndrome (APS) are related to the activity of
circulating antiphospholipid antibodies (aPLs) associated with vascular thrombosis and …

[HTML][HTML] Molecular mechanisms of “antiphospholipid antibodies” and their paradoxical role in the pathogenesis of “seronegative APS”

R Misasi, A Longo, S Recalchi, D Caissutti… - International Journal of …, 2020 - mdpi.com
Antiphospholipid Syndrome (APS) is an autoimmune disease characterized by arterial
and/or venous thrombosis and/or pregnancy morbidity, associated with circulating …

Platelet activation by antiphospholipid antibodies depends on epitope specificity and is prevented by mTOR inhibitors

A Hollerbach, N Müller-Calleja, S Ritter… - Thrombosis and …, 2019 - thieme-connect.com
Antiphospholipid antibodies (aPL) have been reported to activate platelets. This is
considered to be one of the pathogenic properties of aPL. Even though aPL heterogeneity is …

[HTML][HTML] Antiphospholipid antibody‐induced cellular responses depend on epitope specificity: implications for treatment of antiphospholipid syndrome

N Müller‐Calleja, A Hollerbach, F Häuser… - Journal of Thrombosis …, 2017 - Elsevier
Essentials• Antiphospholipid antibodies (aPL) are heterogeneous and induce different
cellular responses.• We analyzed signaling events induced by different monoclonal and …

Antiphospholipid syndrome: an update for clinicians and scientists

AP Vreede, PL Bockenstedt… - Current opinion in …, 2017 - journals.lww.com
Antiphospholipid syndrome: an update for clinicians and scie... : Current Opinion in
Rheumatology Antiphospholipid syndrome: an update for clinicians and scientists : Current …

[HTML][HTML] Managing antiphospholipid syndrome in children and adolescents: current and future prospects

AG Islabao, VC Trindade, LMH da Mota, DCO Andrade… - Pediatric Drugs, 2022 - Springer
Pediatric antiphospholipid syndrome (APS) is a rare acquired multisystem autoimmune
thromboinflammatory condition characterized by thrombotic and non-thrombotic clinical …

Pathogenesis of antiphospholipid syndrome: recent insights and emerging concepts

KJ Lackner, N Müller-Calleja - Expert review of clinical immunology, 2019 - Taylor & Francis
Introduction: Even though our understanding of the antiphospholipid syndrome (APS) has
improved tremendously over the last decades, we are still not in a position to replace …